Artykuły w czasopismach na temat „Hypercholesteremia”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Hypercholesteremia”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Visavadiya, Nishant P., i A. V. R. L. Narasimhacharya. "AsparagusRoot Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats". Evidence-Based Complementary and Alternative Medicine 6, nr 2 (2009): 219–26. http://dx.doi.org/10.1093/ecam/nem091.
Pełny tekst źródłaKamalova, Aelita A. "Diet Therapy in Children with Hypercholesteremia". Current Pediatrics 19, nr 4 (19.09.2020): 309–15. http://dx.doi.org/10.15690/vsp.v19i4.2140.
Pełny tekst źródłaDietrich, Hans H. "Apolipoprotein E in Hypercholesteremia and Beyond". Stroke 38, nr 7 (lipiec 2007): 2036. http://dx.doi.org/10.1161/strokeaha.107.489856.
Pełny tekst źródłaLEWIS, S. "P514 Hypercholesteremia induces baroreceptro reflex dysfunction". European Heart Journal 24, nr 5 (marzec 2003): 81. http://dx.doi.org/10.1016/s0195-668x(03)93952-2.
Pełny tekst źródłaNAKAI, TSUGUHIKO. "Familial hypercholesteremia complicated by nephrotic syndrome." Nihon Naika Gakkai Zasshi 79, nr 8 (1990): 1079–80. http://dx.doi.org/10.2169/naika.79.1079.
Pełny tekst źródłaHURLEY, D. "Hypercholesteremia induces enhanced circulating inflammatory activity". American Journal of Hypertension 17, nr 5 (maj 2004): S242. http://dx.doi.org/10.1016/j.amjhyper.2004.03.648.
Pełny tekst źródłaLi, Nan F., Hong M. Wang, Jin Yang, Ling Zhou, Xiao G. Yao i Jing Hong. "Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population". Applied Physiology, Nutrition, and Metabolism 34, nr 6 (grudzień 2009): 1032–39. http://dx.doi.org/10.1139/h09-101.
Pełny tekst źródłaNichols, E. H., i M. R. Jaff. "Hypercholesteremia, Hypertension, and Antiplatelet Therapy in PAD". MD Conference Express 13, nr 19 (1.12.2013): 31. http://dx.doi.org/10.1177/155989771319015.
Pełny tekst źródłaKumawat, Vinod Bihari, Surendra Kumar Sharma, Uttam Kumar Sharma i Sudhir Sharma. "Effect of trikatu compound in hypercholesteremia- a clinical study". Environment Conservation Journal 16, nr 1&2 (12.06.2015): 57–61. http://dx.doi.org/10.36953/ecj.2015.161209.
Pełny tekst źródłaTokura, T. "Changes in Bruch's Membrane in Experimental Hypercholesteremia in Rats". Japanese Journal of Ophthalmology 43, nr 4 (8.07.1999): 337–38. http://dx.doi.org/10.1016/s0021-5155(99)00055-6.
Pełny tekst źródłaBARTON, M. "Hypercholesteremia induces cardiac concentric remodeling in the guinea pig". American Journal of Hypertension 17, nr 5 (maj 2004): S165—S166. http://dx.doi.org/10.1016/j.amjhyper.2004.03.434.
Pełny tekst źródłaElbadawi, Ayman, Islam Y. Elgendy, Mohamed Omer, Mohamed Abdelazeem, Vijay Nambi, Chayakrit Krittanawong, Ravi S. Hira, Jacqueline Tamis-Holland, Christie Ballantyne i Hani Jneid. "Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia". American Journal of Medicine 134, nr 8 (sierpień 2021): 992–1001. http://dx.doi.org/10.1016/j.amjmed.2021.03.013.
Pełny tekst źródłaYu, Lianlong, Qianrang Zhu, Yuqian Li, Pengkun Song i Jian Zhang. "Dietary Branched-Chain Amino Acids (BCAAs) and Risk of Dyslipidemia in a Chinese Population". Nutrients 14, nr 9 (27.04.2022): 1824. http://dx.doi.org/10.3390/nu14091824.
Pełny tekst źródłaNagaraj, Lavanya, i Naveen Kumar Madalageri. "A comparative study of metabolic side effects of risperidone and olanzapine in the treatment of schizophrenia". International Journal of Basic & Clinical Pharmacology 8, nr 11 (22.10.2019): 2561. http://dx.doi.org/10.18203/2319-2003.ijbcp20194803.
Pełny tekst źródłaKoo, Hui Chin, Lay Kim Tan, Geok Pei Lim, Chee Cheong Kee i Mohd Azahadi Omar. "Obesity and Its Association with Undiagnosed Diabetes Mellitus, High Blood Pressure and Hypercholesterolemia in the Malaysian Adult Population: A National Cross-Sectional Study Using NHMS Data". International Journal of Environmental Research and Public Health 20, nr 4 (9.02.2023): 3058. http://dx.doi.org/10.3390/ijerph20043058.
Pełny tekst źródłaDidia, S. Claudia. "PCSK9-Inhibitors: A Review of a Novel Approach in Hypercholesteremia Management". Medical Science Review 1 (2014): 1–6. http://dx.doi.org/10.12659/msrev.890836.
Pełny tekst źródłaVerma, Isha, Antonio Fernandez i Paul Thompson. "FAMILIAL HYPERCHOLESTEREMIA: WHEN STATINS, EZETIMIBE & PCSK9 INHIBITORS ARE NOT ENOUGH". Journal of the American College of Cardiology 71, nr 11 (marzec 2018): A2439. http://dx.doi.org/10.1016/s0735-1097(18)32980-2.
Pełny tekst źródłaVerma, Isha, Paul D. Thompson i Antonio B. Fernandez. "Familial Hypercholesteremia: When Statins, Ezetimibe & PCSK9 Inhibitors Are Not Enough". Journal of Clinical Lipidology 12, nr 2 (marzec 2018): 545. http://dx.doi.org/10.1016/j.jacl.2018.03.043.
Pełny tekst źródłaValentine, V. G., L. Seoane, D. M. Fuchs, S. G. LaPlace, G. A. Lombard i D. E. Taylor. "Potential benefits of treating hypercholesteremia and hypertension in lung allograft recipients". Journal of Heart and Lung Transplantation 24, nr 2 (luty 2005): S170. http://dx.doi.org/10.1016/j.healun.2004.12.105.
Pełny tekst źródłaMUNDAY, J. "Hypercholesteremia-induced changes in left ventricular geometry in the guinea pig". American Journal of Hypertension 17, nr 5 (maj 2004): S168. http://dx.doi.org/10.1016/j.amjhyper.2004.03.441.
Pełny tekst źródłaFan, Jing, Caicui Ding, Weiyan Gong, Fan Yuan, Yanning Ma, Ganyu Feng, Chao Song i Ailing Liu. "The Relationship between Leisure-Time Sedentary Behaviors and Metabolic Risks in Middle-Aged Chinese Women". International Journal of Environmental Research and Public Health 17, nr 19 (30.09.2020): 7171. http://dx.doi.org/10.3390/ijerph17197171.
Pełny tekst źródłaZhang, Haoqiang, Rong Huang, Sai Tian, Ke An, Wenwen Zhu, Jijing Shi, Wuyou Cao i Shaohua Wang. "The CC Genotype of Insulin-Induced Gene 2 rs7566605 Is a Protective Factor of Hypercholesteremia Susceptible to Mild Cognitive Impairment, Especially to the Executive Function of Patients with Type 2 Diabetes Mellitus". BioMed Research International 2020 (10.06.2020): 1–7. http://dx.doi.org/10.1155/2020/4935831.
Pełny tekst źródłaJha, Niharika, i Vanya Narayan. "Multiple giant tuberous xanthomas with type IIa hypercholesteremia in a young male". Indian Journal of Dermatopathology and Diagnostic Dermatology 7, nr 1 (2020): 38. http://dx.doi.org/10.4103/ijdpdd.ijdpdd_40_20.
Pełny tekst źródłaMiyayama, Takeshi, Shin-ichiro Miura, Tomo Komaki, Takashi Kuwano, Joji Morii, Hiroaki Nishikawa i Keijiro Saku. "Acute Myocardial Infarction in a 26-Year-Old Patient With Familial Hypercholesteremia". Journal of Clinical Medicine Research 8, nr 7 (2016): 562–65. http://dx.doi.org/10.14740/jocmr2596w.
Pełny tekst źródłaYakimenko, O., i Ie Maznichenko. "COMPLEX HYPOLIPIDEMIC THERAPY OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND FAMILIAL HYPERCHOLESTEREMIA". Bulletin of Problems Biology and Medicine 1, nr 2 (2019): 207. http://dx.doi.org/10.29254/2077-4214-2019-1-2-149-207-211.
Pełny tekst źródłaHyvärinen, Lea. "FLUORESCENCE CINEANGIOGRAPHIC AND HISTOLOGICAL STUDIES ON THE RABBIT EYE DURING EXPERIMENTAL HYPERCHOLESTEREMIA". Acta Ophthalmologica 46, nr 1 (27.05.2009): 57–70. http://dx.doi.org/10.1111/j.1755-3768.1968.tb02495.x.
Pełny tekst źródłaHarper, Claudia, Radhika Seimon, Brendon Yee, Amanda Sainsbury i Elizabeth Cayanan. "Translating Evidence into Practice: A Case Study of Extended Use of a Very Low Energy Diet for Treatment of Co-Morbid Obesity and Chronic Disease". Recent Progress in Nutrition 2, nr 2 (21.02.2022): 1. http://dx.doi.org/10.21926/rpn.2202015.
Pełny tekst źródłaBarrios, Vivencio, i Carlos Escobar. "Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk". Expert Review of Clinical Pharmacology 14, nr 7 (24.05.2021): 793–806. http://dx.doi.org/10.1080/17512433.2021.1925539.
Pełny tekst źródłaGodal, H. C., J. C. Lund i E. Sivertssen. "LIPIDS AND LIPOPROTEINS IN SERUM IN CASES OF FAMILIAL ESSENTIAL HYPERCHOLESTEREMIA AND XANTHOMATOSIS." Acta Medica Scandinavica 156, S319 (24.04.2009): 125–34. http://dx.doi.org/10.1111/j.0954-6820.1956.tb06306.x.
Pełny tekst źródłaLi, Zhi-Zhao, Qiong Huang, Xiao-li Yang, Jieqiong Zeng, QI-Hui Wang, Hai-Ming Tang, Zhen-qiu Yu, Yu-Qing Song i Yang Liu. "Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia". Disease Markers 2022 (21.04.2022): 1–9. http://dx.doi.org/10.1155/2022/2008556.
Pełny tekst źródłaRANA, MOHAMMAD MOHSIN, BADAR BASHIR, MUHAMMAD SAEED AKHTAR i Abaid Ur-Rehman. "TYPE 2 DIABETICS". Professional Medical Journal 14, nr 02 (6.09.2007): 337–43. http://dx.doi.org/10.29309/tpmj/2007.14.02.4900.
Pełny tekst źródłaYuefeng, Yu, Lin Zhiqi, Chen Yi, Zhu Keyu, Wan Heng, Wang Yuying, Wang Ningjian i in. "Testosterone Deficiency Promotes Hypercholesteremia and Attenuates Cholesterol Liver Uptake via AR/PCSK9/LDLR Pathways". International Journal of Endocrinology 2022 (13.05.2022): 1–10. http://dx.doi.org/10.1155/2022/7989751.
Pełny tekst źródłaDrew-Nord, Dana C., OiSaeng Hong, Erika S. Froelicher, Phyllis Berryman i Eileen Lukes. "Cardiovascular Risk Factors among Career Firefighters". AAOHN Journal 57, nr 10 (październik 2009): 415–24. http://dx.doi.org/10.1177/216507990905701004.
Pełny tekst źródłaBardia, A., i G. Garg. "Mipomersen For Treatment Of Hypercholesteremia: Evidence Review And Meta Analytic Evaluation Of Randomized Controlled Trials". Value in Health 18, nr 3 (maj 2015): A132. http://dx.doi.org/10.1016/j.jval.2015.03.771.
Pełny tekst źródłaNaik, Aleš Belič Adviti. "Analysis of the Cholesterol Biosynthesis Feedback Control and its Consequences for the Hypercholesteremia Treatment Strategies". IFAC Proceedings Volumes 45, nr 2 (2012): 624–28. http://dx.doi.org/10.3182/20120215-3-at-3016.00111.
Pełny tekst źródłaHuige, M. C., J. J. R. M. Bonnier, H. J. Rila, L. J. Jansen, K. te VElde, A. J. te Rijdt, P. de Weerd i P. A. Leijten. "Efficacy and safety of pravastatin in Dutch patients with hypercholesteremia and additional coronary risk factors". Atherosclerosis 115 (czerwiec 1995): S128. http://dx.doi.org/10.1016/0021-9150(95)96739-f.
Pełny tekst źródłaCheung, Brian, Jay Hwang, Ania Stolarczyk, Elliot Mahlof i Robert Block. "Case Study of Hypertriglyceridemia from COVID-19 Pfizer-BioNTech Vaccination in a Patient with Familial Hypercholesteremia". Journal of Clinical Lipidology 16, nr 1 (styczeń 2022): e13-e14. http://dx.doi.org/10.1016/j.jacl.2021.09.019.
Pełny tekst źródłaKirkorowicz, JM, P. Sapukotana, PV De Silva, M. Noda, JS De Oliveira i T. Østbye. "Work-Related Stress and Substance Use as Risk Factors for Chronic Disease Among Three-Wheel Drivers in Galle, Sri Lanka: A Qualitative Study". International Journal of Occupational Safety and Health 3, nr 2 (10.02.2014): 21–24. http://dx.doi.org/10.3126/ijosh.v3i2.7662.
Pełny tekst źródłaEzratty, Ellen J., Claire Bertaux, Eugene E. Marcantonio i Gregg G. Gundersen. "Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells". Journal of Cell Biology 187, nr 5 (30.11.2009): 733–47. http://dx.doi.org/10.1083/jcb.200904054.
Pełny tekst źródłaCHISAKA, TAKESHI, HISASHI MATSUDA, YASUSHI KUBOMURA, MICHIHIKO MOCHIZUKI, JOHJI YAMAHARA i HAJIME FUJIMURA. "The effect of crude drugs on experimental hypercholesteremia: Mode of action of (-)-epigallocatechin gallate in tea leaves." CHEMICAL & PHARMACEUTICAL BULLETIN 36, nr 1 (1988): 227–33. http://dx.doi.org/10.1248/cpb.36.227.
Pełny tekst źródłaWeng, Pei-Hsuan, Jen-Hau Chen, Ta-Fu Chen, Yu Sun, Li-Li Wen, Ping-Keung Yip, Yi-Min Chu i Yen-Ching Chen. "P3-253: Interactions between ApoE ε4 status and hypercholesteremia on response to acetylcholinesterase inhibitor in Alzheimer's disease". Alzheimer's & Dementia 11, nr 7S_Part_16 (lipiec 2015): P728. http://dx.doi.org/10.1016/j.jalz.2015.06.1626.
Pełny tekst źródłaMIYAMURA, Mitsuhiko, Hironori MORIYAMA, Shuuzo MURATA, Junko YOKOTA, Saburo YOSHIOKA, Daisuke TAKUMA, Atsuhide HAMADA i Yutaka NISHIOKA. "Inhibitory Effects of “Goishi-tea” as a Post-Fermented-tea on Dietary-Induced Hypercholesteremia and Atherosclerosis in Rabbits". YAKUGAKU ZASSHI 128, nr 7 (1.07.2008): 1037–44. http://dx.doi.org/10.1248/yakushi.128.1037.
Pełny tekst źródłaAhualli, L., A. Stewart-Harris, G. Bastianelli, D. Radlovachki, A. Bartolomé, P. L. Trigo, N. Cejas i in. "Combined Cardiohepatic Transplantation Due to Severe Heterozygous Familiar Hypercholesteremia Type II: First Case in Argentina—A Case Report". Transplantation Proceedings 39, nr 7 (wrzesień 2007): 2449–53. http://dx.doi.org/10.1016/j.transproceed.2007.07.068.
Pełny tekst źródłaMatlock, John P., i J. E. Nixon. "Impaired clearance, elimination, and metabolism of plasma cholesterol esters associated with hypercholesteremia in mice fed cyclopropenoid fatty acids". Toxicology and Applied Pharmacology 84, nr 1 (czerwiec 1986): 3–11. http://dx.doi.org/10.1016/0041-008x(86)90411-4.
Pełny tekst źródłaKamal, Shymaa, Ragaa A. Hamouda, Hoda Mahrous, Mohammed Labib Salem, Hanafy A. Hamza i Ekbal Abd Elhafez. "In vitro Treatment with Intact Cells or Cell Lysates of Lactobacillus and Spirulina Induced Lowering Effects on Induced Hypercholesteremia". International Journal of Pharmacology 11, nr 6 (1.08.2015): 638–43. http://dx.doi.org/10.3923/ijp.2015.638.643.
Pełny tekst źródłaKim, Beob-Jin, Yeon-Kye Kim, Won-Hwan Park, Jeong-Heon Ko, Young-Choon Lee i Cheorl-Ho Kim. "A water-extract of the Korean traditional formulation Geiji–Bokryung–Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits". International Immunopharmacology 3, nr 5 (maj 2003): 723–34. http://dx.doi.org/10.1016/s1567-5769(03)00073-0.
Pełny tekst źródłaGopinathanpillai, Kalavarasariel, Eluri Kalpana, Balasubramaniam Dineshkumar, Elumalai Monogaran, Govindharajalu Geetha i Ramasamy Venkatanarayanan. "Tetrahydrocurcumin: Beneficial Effects on HMG-CoA Reductase enzyme and Lipoprotein Lipase Enzymes in High-fat diet-induced Hypercholesteremia Rabbits". Pharmacognosy Communications 2, nr 2 (19.04.2012): 50–60. http://dx.doi.org/10.5530/pc.2012.2.8.
Pełny tekst źródłaLi, Yun-Xi, Chao-Qun Lin, Da-Yu Shi, Shu-Ying Zeng i Wen-Sheng Li. "Upregulated expression of human alpha-defensins 1, 2 and 3 in hypercholesteremia and its relationship with serum lipid levels". Human Immunology 75, nr 11 (listopad 2014): 1104–9. http://dx.doi.org/10.1016/j.humimm.2014.09.014.
Pełny tekst źródłaWeintraub, Spencer, Jessica A. Schillow, Bani Azari i Benjamin Hirsh. "IMPLEMENTATION TIMELINE OF NOVEL LIPID LOWERING THERAPIES IN A REFRACTORY COMPOUND HETEROZYGOUS FAMILIAL HYPERCHOLESTEREMIA PATIENT WITH SEVERE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE". Journal of the American College of Cardiology 79, nr 9 (marzec 2022): 3186. http://dx.doi.org/10.1016/s0735-1097(22)04177-8.
Pełny tekst źródłaRani, Pratibha, Kamaldeep Singh, Anania Arjuna i Savita Devi. "GENETIC DISORDER ALZHEIMER". Asian Journal of Pharmaceutical and Clinical Research 10, nr 12 (1.12.2017): 36. http://dx.doi.org/10.22159/ajpcr.2017.v10i12.18684.
Pełny tekst źródła